The latest cancer drugs news

The latest cancer drugs news
Novartis today announced updated median overall survival (OS) results for ribociclib in combination with fulvestrant…
Immune checkpoint inhibitors are widely used to treat a variety of cancers; however, one serious…
Epigenetic drugs that have shown promise in cancer trials significantly reduce scarring in the cells…
Results from an interim analysis of the phase III RATIONALE 306 study, showed anti-PD-1 immune…
This content is password protected. To view it please enter your password below: Password:
Merck and Pfizer have announced that, following a successful appeal of the prior Final Appraisal…
The Food and Drug Administration have approved lutetium Lu 177 vipivotide tetraxetan (Pluvicto) for the…
On March 18, 2022, the Food and Drug Administration approved nivolumab and relatlimab-rmbw for adult and…
The Institute of Cancer Research, London, UK, strongly welcomes new findings that the targeted drug…
A new study suggests that the malaria drug hydroxychloroquine inhibits pathways that drive resistance to…